Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION
Firm Income Reported for This Client
$595K
Not substituted for client expenses
Summary
HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION is an organization, based in MD. Its political footprint includes $595K in lobbying-firm income reported for this client. Lobbying activity focuses on Defense, Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations. Political activity spans from 2010 to 2026.